What to watch during JPM week; telehealth abortion providers eye new options for patients

STAT polled biotech insiders for what's on their minds ahead of a not-so-celebratory JPM week. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: Money troubles and M&A: What's on biotech insiders' minds ahead of a not-so-celebratory JPM week By Adam Feuerstein and Allison DeAngelis Mike Reddy for STAT Nearly 70% of biotech insiders say financing — such as raising venture capital or launching an IPO — will be a challenge in 2023. Read More Telehealth abortion providers eye new options for patients under loosened FDA rules By Katie Palmer Alex Hogan/STAT Several telemedicine companies that provide medication abortion expressed enthusiasm for local pickup options under new FDA rules. Read More STAT+: The health care providers and insurers we're watching at JPM23 — and why By Bob Herman and Tara Bannow Adobe STAT's Bob Herman and Tara Bannow lay out which health care providers and insurance companies they'll be watching at JPM23. Read More Sponsored Insight by Humana Home-based care: An old approach that's transforming healthcare The pandemic created opportunities to rethink ways we provide healthcare to ensure everyone has access to high quality, affordable care on their own terms – one of those approaches is in-home healthcare. Andrew Agwunobi, M.D., MBA, President of Humana Home Solutions, discusses the benefits of providing care in the home including building more trusting relationships between patients and clinicians, allowing for more in-depth conversations and limiting exposure to illness and infection, especially among older adults. Read more. 'I want people to see us': A writer gives voice to long Covid and mothering from bed By Isabella Cueto Photo illustration: Casey Shenery for STAT Kristin Houlihan started writing to give visibility and solidarity to people with long Covid, chronic fatigue, and other conditions. Read More STAT+: A flurry of pharma acquisitions kick off JPM week after a slow year for deals By Jonathan Wosen and Allison DeAngelis Raphael Lafargue/Abaca/Sipa USA via AP Four life science companies have announced acquisitions worth roughly $4.5 billion in total, raising hopes that 2023 will yield more M&A. Read More India's lax oversight of pharmaceutical manufacturing imperils health around the world By Patrick Skerrett XAVIER GALIANA/AFP via Getty Images More aggressive and transparent regulation and oversight of India's pharmaceutical companies are needed to protect lives everywhere. Read More STAT+: Novavax replaces CEO, citing need for 'fresh perspective' By Matthew Herper JUSTIN TALLIS/AFP via Getty Images After being chosen to be develop a Covid vaccine as part of Operation Warp Speed, Novavax hit manufacturing issues and regulatory roadblocks. Read More STAT+: Regeneron's Eylea sales dip, as competition looms By Jason Mast Kristoffer Tripplaar/Sipa via AP Wall Street had been watching to see if biosimilars and other new rivals would cut into the huge sales of the macular degeneration drug Eylea. Read More Monday, January 9, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser